Large US study suggests survival benefit for severely ill COVID-19 patients treated with ECMO
AstraZeneca suffers diabetes drug setback for COVID
12 April 2021The COVID-19 pandemic has been linked with six unhealthy eating behaviors
12 April 2021Large US study suggests survival benefit for severely ill COVID-19 patients treated with ECMO
For critically ill COVID-19 patients treated with extracorporeal membrane oxygenation (ECMO), the risk of death remains high—but is much lower than suggested by initial studies, according to a report published today by Annals of Surgery.
